Table 5 Comparison between group A and group B regarding laboratory and radiological findings before vitamin D supplementation

TLC (10³/Ul)

Mean ± SD

6.44 ± 1.67

6.88 ± 2.22

 − 0.541^b

0.594

NS

Range

3.9–10.3

3.7–9.6

Hb (g/dl)

Mean ± SD

11.07 ± 1.05

11.20 ± 1.57

 − 0.245^b

0.809

NS

Range

8.4–12.6

8.2–13.6

PLTs (10³/Ul)

Median (IQR)

268 (169.5–403)

279.5 (189.5–311)

 − 0.231^c

0.817

NS

Range

83–484

61–523

ALT (IU/l)

Median (IQR)

63 (27–231)

39.5 (28.5–53)

 − 1.184^c

0.236

NS

Range

14–642

14–398

AST (IU/l)

Median (IQR)

62.5 (43.5–348.5)

48.5 (42–77)

 − 0.635^c

0.525

NS

Range

20–676

29–919

Gama GT

Median (IQR)

55.5 (39–70)

89 (51–122)

 − 1.530^c

0.126

NS

Range

24–131

34–170

Total bilirubin (mg/dl)

Median (IQR)

0.85 (0.65–1.4)

0.75 (0.5–1.15)

 − 0.521^c

0.603

NS

Range

0.2–2.4

0.3–2.4

Direct bilirubin (mg/dl)

Median (IQR)

0.25 (0.11–0.55)

0.15 (0.1–0.3)

 − 1.013^c

0.311

NS

Range

0.1–0.8

0.1–1.6

Albumin (g/dl)

Mean ± SD

3.95 ± 0.50

4.03 ± 0.42

 − 0.398

0.695

NS

Range

3.1–4.5

3.3–4.6

INR

Mean ± SD

1.26 ± 0.40

1.17 ± 0.18

0.774

0.447

NS

Range

0.9–1.9

1–1.54

Child–Pugh score

Median (IQR)

6.00 (6.00–8.50)

6.00 (5.50–7.50)

 − 0.991^c

0.322

NS

Range

5.00–13.00

5.00–13.00

Child–Pugh score

Class A

7 (58.3%)

9 (75.0%)

0.783^a

0.676

NS

Class B

3 (25.0%)

2 (16.7%)

Class C

2 (16.7%)

1 (8.3%)

PA ultrasound

Normal

2 (16.7%)

2 (16.7%)

2.000^a

0.572

NS

Hepatosplenomegaly

6 (50.0%)

3 (25.0%)

Hepatomegaly

3 (25.0%)

6 (50.0%)

Cirrhotic liver

1 (8.3%)

1 (8.3%)

Fibroscan (kPa)

Median (IQR)

6.45(5.85–8.2)

6.05(4.8–8.2)

 − 0.492^c

0.623

NS

Range

3.3–17.9

4–20.6

F0

6 (50.0%)

6 (50.0%)

3.200^a

0.783

NS

F1

0 (0.0%)

1 (8.3%)

F2

2 (16.6%)

1 (8.3%)

F3

3 (25.0%)

3 (25%)

F4

1 (8.3%)

1 (8.3%)